$NVCR
NovoCure Ltd Stock $nvcr

$nvcr Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000164511320000105 Filed on July 30, 2020

Income Statement

Concept	2020 Q2	2019 Q2	2019 Q1
Revenue	$115.9M	$86.71M	$73.31M
YoY Change	33.69%	40.96%	40.64%
Cost Of Revenue	$25.47M	$21.11M	$19.81M
YoY Change	20.7%	6.42%	8.87%
Gross Profit	$90.45M	$65.61M	$53.50M
YoY Change	37.87%	57.4%	57.86%
Gross Profit Margin	78.03%	75.66%	72.97%
Selling, General & Admin	$53.87M	$44.96M	$42.57M
YoY Change	19.81%	20.19%	19.92%
% of Gross Profit	59.55%	68.52%	79.58%
Research & Development	$29.92M	$19.45M	$17.04M
YoY Change	53.79%	71.22%	53.53%
% of Gross Profit	33.08%	29.65%	31.86%
Depreciation & Amortization	$2.600M	$2.130M	$1.930M
YoY Change	22.07%	-6.99%	-12.27%
% of Gross Profit	2.87%	3.25%	3.61%
Operating Expenses	$83.78M	$64.41M	$59.61M
YoY Change	30.08%	32.08%	27.92%
Operating Profit	$6.668M	$1.196M	-$6.118M
YoY Change	457.53%	-116.88%	-51.74%
Interest Expense	-$2.600M	-$1.200M	-$2.400M
YoY Change	116.67%	-58.62%	-51.02%
% of Operating Profit	-38.99%	-100.33%
Other Income/Expense, Net
YoY Change
Pretax Income	$4.051M	-$43.00K	-$8.489M
YoY Change	-9520.93%	-99.57%	-51.49%
Income Tax	$2.396M	$1.227M	$3.661M
% Of Pretax Income	59.15%
Net Earnings	$1.655M	-$1.270M	-$12.15M
YoY Change	-230.31%	-91.81%	-41.37%
Net Earnings / Revenue	1.43%	-1.46%	-16.57%
Basic Earnings Per Share	$0.02	-$0.01	-$0.13
Diluted Earnings Per Share	$0.02	-$0.01	-$0.13
COMMON SHARES
Basic Shares Outstanding	100.7M shares	96.36M shares	94.81M shares
Diluted Shares Outstanding	107.6M shares	96.36M shares	94.81M shares

Balance Sheet

Concept	2020 Q2	2019 Q2	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$346.7M	$284.6M	$256.6M
YoY Change	21.82%	29.95%	18.63%
Cash & Equivalents	$196.8M	$180.1M	$154.2M
Short-Term Investments	$149.9M	$104.5M	$104.5M
Other Short-Term Assets	$800.0K	$2.100M	$2.100M
YoY Change	-61.9%	-4.55%	-4.55%
Inventory	$26.14M	$25.45M	$24.10M
Prepaid Expenses
Receivables	$76.03M	$42.53M	$39.20M
Other Receivables	$38.10M	$15.30M	$13.60M
Total Short-Term Assets	$487.8M	$370.0M	$335.7M
YoY Change	31.84%	27.62%	18.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.53M	$8.399M	$29.60M
YoY Change	25.37%	-50.59%	65.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.860M	$5.682M	$5.000M
YoY Change	-14.47%	89.4%	85.19%
Total Long-Term Assets	$41.16M	$36.21M	$34.60M
YoY Change	13.68%	81.03%	67.15%
TOTAL ASSETS
Total Short-Term Assets	$487.8M	$370.0M	$335.7M
Total Long-Term Assets	$41.16M	$36.21M	$34.60M
Total Assets	$528.9M	$406.2M	$370.3M
YoY Change	30.22%	31.07%	22.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$38.50M	$30.10M	$29.90M
YoY Change	27.91%	47.55%	54.12%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$85.12M	$73.57M	$70.90M
YoY Change	15.71%	62.76%	58.26%
LONG-TERM LIABILITIES
Long-Term Debt	$149.5M	$149.3M	$149.3M
YoY Change	0.11%	0.1%	0.07%
Other Long-Term Liabilities	$173.0K	$306.0K	$23.60M
YoY Change	-43.46%	-91.0%	594.12%
Total Long-Term Liabilities	$176.0M	$173.7M	$172.9M
YoY Change	1.31%	13.84%	13.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$85.12M	$73.57M	$70.90M
Total Long-Term Liabilities	$176.0M	$173.7M	$172.9M
Total Liabilities	$261.1M	$247.3M	$243.9M
YoY Change	5.59%	25.02%	23.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$645.3M	-$657.1M
YoY Change	-1.8%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$267.8M	$158.9M	$126.4M
YoY Change
Total Liabilities & Shareholders Equity	$528.9M	$406.2M	$370.3M
YoY Change	30.22%	31.07%	22.01%

Cashflow Statement

Concept	2020 Q2	2019 Q2	2019 Q1
OPERATING ACTIVITIES
Net Income	$1.655M	-$1.270M	-$12.15M
YoY Change	-230.31%	-91.81%	-41.37%
Depreciation, Depletion And Amortization	$2.600M	$2.130M	$1.930M
YoY Change	22.07%	-6.99%	-12.27%
Cash From Operating Activities	$12.74M	$9.066M	-$4.315M
YoY Change	40.54%	-220.99%	-74.35%
INVESTING ACTIVITIES
Capital Expenditures	$3.315M	$2.397M	$2.325M
YoY Change	38.3%	180.68%	215.47%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$650.0K	$1.340M
YoY Change	-100.0%	4.84%	436.0%
Cash From Investing Activities	-$3.315M	-$1.748M	-$989.0K
YoY Change	89.65%	107.6%	-46.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.667M	$1.208M	$0.00
YoY Change	38.0%	28.78%
Debt Paid & Issued, Net	$7.000K	$8.000K	$8.000K
YoY Change	-12.5%		-99.99%
Cash From Financing Activities	$5.345M	$20.66M	$16.97M
YoY Change	-74.12%	84.64%	-67.18%
NET CHANGE
Cash From Operating Activities	$12.74M	$9.066M	-$4.315M
Cash From Investing Activities	-$3.315M	-$1.748M	-$989.0K
Cash From Financing Activities	$5.345M	$20.66M	$16.97M
Net Change In Cash	$14.88M	$28.02M	$11.41M
YoY Change	-46.9%	878.42%	-65.48%
FREE CASH FLOW
Cash From Operating Activities	$12.74M	$9.066M	-$4.315M
Capital Expenditures	$3.315M	$2.397M	$2.325M
Free Cash Flow	$9.426M	$6.669M	-$6.640M
YoY Change	41.34%	-179.9%	-62.19%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001645113
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37565
	dei	Entity Registrant Name EntityRegistrantName	NovoCure Limited
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Y9
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1057807
	dei	Entity Address Address Line1 EntityAddressAddressLine1	No. 4 The Forum
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Grenville Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	St. Helier
	dei	Entity Address Country EntityAddressCountry	JE
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	JE2 4UF
	dei	City Area Code CityAreaCode	44 (0) 15
	dei	Local Phone Number LocalPhoneNumber	3475 6700
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	58859000	USD
CY2020Q2	nvcr	Receivables And Prepaid Expenses ReceivablesAndPrepaidExpenses	38104000	USD
CY2019Q4	nvcr	Receivables And Prepaid Expenses ReceivablesAndPrepaidExpenses	29202000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	26136000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	23701000	USD
CY2020Q2	us-gaap	Assets Current AssetsCurrent	487781000	USD
	dei	Security12b Title Security12bTitle	Ordinary Shares, no par value
	dei	Trading Symbol TradingSymbol	NVCR
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	101091110	shares
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	196784000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	177321000	USD
CY2020Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	149930000	USD
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	148769000	USD
CY2020Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	801000	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	2095000	USD
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	76026000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	439947000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10530000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9342000	USD
CY2020Q2	nvcr	Field Equipment Net Noncurrent FieldEquipmentNetNoncurrent	8339000	USD
CY2019Q4	nvcr	Field Equipment Net Noncurrent FieldEquipmentNetNoncurrent	7684000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17429000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17571000	USD
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4860000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4904000	USD
CY2020Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	41158000	USD
CY2019Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	39501000	USD
CY2020Q2	us-gaap	Assets Assets	528939000	USD
CY2019Q4	us-gaap	Assets Assets	479448000	USD
CY2020Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	38506000	USD
CY2019Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	36925000	USD
CY2020Q2	nvcr	Other Accounts Payable Lease Liabilites And Accrued Expenses Current OtherAccountsPayableLeaseLiabilitesAndAccruedExpensesCurrent	46615000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14140000	USD
CY2020Q2	nvcr	Employee Related Liabilities Non Current EmployeeRelatedLiabilitiesNonCurrent	4626000	USD
CY2019Q4	nvcr	Other Accounts Payable Lease Liabilites And Accrued Expenses Current OtherAccountsPayableLeaseLiabilitesAndAccruedExpensesCurrent	49386000	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	85121000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	86311000	USD
CY2020Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	149507000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	149424000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	8022000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7807000	USD
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13668000	USD
CY2019Q4	nvcr	Employee Related Liabilities Non Current EmployeeRelatedLiabilitiesNonCurrent	3754000	USD
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	173000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	222000	USD
CY2020Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	175996000	USD
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	175347000	USD
CY2020Q2	us-gaap	Liabilities Liabilities	261117000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	261658000	USD
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101020721	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101020721	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99528435	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99528435	shares
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2020Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	916632000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	871442000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3532000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2767000	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-645278000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-650885000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	267822000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	217790000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	528939000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	479448000	USD
CY2020Q2	us-gaap	Revenues Revenues	115925000	USD
CY2019Q2	us-gaap	Revenues Revenues	86713000	USD
	us-gaap	Revenues Revenues	217753000	USD
	us-gaap	Revenues Revenues	160022000	USD
CY2019	us-gaap	Revenues Revenues	351318000	USD
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	25474000	USD
CY2019Q2	us-gaap	Cost Of Revenue CostOfRevenue	21106000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	49970000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	40920000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	88606000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	90451000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	65607000	USD
	us-gaap	Gross Profit GrossProfit	167783000	USD
	us-gaap	Gross Profit GrossProfit	119102000	USD
CY2019	us-gaap	Gross Profit GrossProfit	262712000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29918000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19454000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55190000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36496000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	79003000	USD
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	28461000	USD
CY2019Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	23708000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	57294000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	46041000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	96675000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25404000	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21249000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	52012000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41487000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	87948000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	83783000	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	64411000	USD
	us-gaap	Operating Expenses OperatingExpenses	164496000	USD
	us-gaap	Operating Expenses OperatingExpenses	124024000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	263626000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	6668000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1196000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	3287000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4922000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-914000	USD
CY2020Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	2617000	USD
CY2019Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1239000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	5049000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	3610000	USD
CY2019	us-gaap	Interest And Debt Expense InterestAndDebtExpense	7910000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4051000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1762000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8532000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8824000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2396000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1227000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7369000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4888000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1594000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	1655000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-1270000	USD
	us-gaap	Net Income Loss NetIncomeLoss	5607000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13420000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7230000	USD
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100718893	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96356317	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100298230	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95583802	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	97237549	shares
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107647802	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96356317	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107897907	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95583802	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	97237549	shares
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	1655000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-1270000	USD
	us-gaap	Net Income Loss NetIncomeLoss	5607000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13420000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7230000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	84000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	47000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-117000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-214000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-304000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-13000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	662000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	648000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	743000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1063000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1752000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1885000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4842000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14377000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8597000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	217790000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16557000	USD
CY2020Q1	nvcr	Stock Issued During Period Value Exercise Of Options And Vested Rs Us StockIssuedDuringPeriodValueExerciseOfOptionsAndVestedRSUs	4511000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-862000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3952000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	241948000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18770000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1667000	USD
CY2020Q2	nvcr	Stock Issued During Period Value Exercise Of Options And Vested Rs Us StockIssuedDuringPeriodValueExerciseOfOptionsAndVestedRSUs	3685000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	97000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	1655000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	267822000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	112259000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9649000	USD
CY2019Q1	nvcr	Stock Issued During Period Value Exercise Of Options And Vested Rs Us StockIssuedDuringPeriodValueExerciseOfOptionsAndVestedRSUs	16978000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-11000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-342000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-12150000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	126394000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13732000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1208000	USD
CY2019Q2	nvcr	Stock Issued During Period Value Exercise Of Options And Vested Rs Us StockIssuedDuringPeriodValueExerciseOfOptionsAndVestedRSUs	19457000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-69000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-615000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-1270000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	158906000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	1655000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-1270000	USD
	us-gaap	Net Income Loss NetIncomeLoss	5607000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13420000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7230000	USD
CY2020Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2601000	USD
CY2019Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2132000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4489000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4061000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8460000	USD
CY2020Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	133000	USD
CY2019Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	86000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	139000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	161000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	398000	USD
CY2020Q2	us-gaap	Share Based Compensation ShareBasedCompensation	18770000	USD
CY2019Q2	us-gaap	Share Based Compensation ShareBasedCompensation	13732000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	35327000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	23381000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-7006000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	52416000	USD
CY2020Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	463000	USD
CY2019Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	470000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	917000	USD
CY2020Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6160000	USD
CY2019Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4998000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	25878000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7034000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	36496000	USD
CY2020Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-538000	USD
CY2019Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-587000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-1078000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-1165000	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-2176000	USD
CY2020Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3539000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2391000	USD
CY2019Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1316000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2899000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1159000	USD
CY2020Q2	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1143000	USD
CY2019Q2	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-168000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-2379000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-82000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-3446000	USD
CY2020Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	405000	USD
CY2019Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2223000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1934000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4469000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	16883000	USD
CY2020Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1266000	USD
CY2019Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1104000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1492000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2885000	USD
CY2019Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9066000	USD
CY2020Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3315000	USD
CY2019Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2397000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6427000	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12741000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14698000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4751000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26620000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4722000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10485000	USD
CY2020Q2	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	0	USD
CY2019Q2	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	105000000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	0	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	210661000	USD
CY2019	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	420661000	USD
CY2020Q2	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
CY2020Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1667000	USD
CY2019Q2	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	104351000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	208676000	USD
CY2019	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	461843000	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3315000	USD
CY2019Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1748000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6427000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2737000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-51667000	USD
CY2019Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1208000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1667000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1208000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2467000	USD
CY2020Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7000	USD
CY2019Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	8000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	15000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14880000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	16000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	31000	USD
CY2020Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3685000	USD
CY2019Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	19457000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8196000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	36435000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	59245000	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5345000	USD
CY2019Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20657000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9848000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37627000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61681000	USD
CY2020Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109000	USD
CY2019Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-214000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	28022000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18169000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	39427000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	36660000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	182705000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	154161000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	179416000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	142756000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	142756000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	197585000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	182183000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	197585000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	182183000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	179416000	USD
CY2020Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4728000	USD
CY2019Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4358000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6937000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7391000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	11241000	USD
CY2020Q2	us-gaap	Interest Paid Net InterestPaidNet	3415000	USD
CY2019Q2	us-gaap	Interest Paid Net InterestPaidNet	3415000	USD
	us-gaap	Interest Paid Net InterestPaidNet	6831000	USD
	us-gaap	Interest Paid Net InterestPaidNet	6794000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	13699000	USD
CY2020Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1391000	USD
CY2019Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1539000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2174000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	17273000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22943000	USD
CY2020Q2	us-gaap	Cash Cash	17589000	USD
CY2019Q4	us-gaap	Cash Cash	18377000	USD
CY2020Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	179195000	USD
CY2019Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	158944000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	196784000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	177321000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	26136000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	23701000	USD
CY2020Q2	us-gaap	Deposits Assets DepositsAssets	1394000	USD
CY2019Q4	us-gaap	Deposits Assets DepositsAssets	1390000	USD
CY2020Q2	us-gaap	Contractual Obligation ContractualObligation	1625000	USD
CY2019Q4	us-gaap	Contractual Obligation ContractualObligation	1557000	USD
CY2020Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	149930000	USD
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	148769000	USD
CY2020Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	149992000	USD
CY2019Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	148738000	USD
CY2020Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5605000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3912000	USD
CY2020Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9331000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6482000	USD
CY2020Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11200000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13308000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	748247	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10350810	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.40
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5360242	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	68.99
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	583753	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	14.06
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	172913	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	18.40
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10342391	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.30
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	16.08
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	583753	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	583753	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1474395	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	30.26
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	3804611	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	53.63
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	875458	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	7599677	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	19.85
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	17587	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	45.05
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	4385961	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	52.55
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18770000	USD
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13732000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35327000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23381000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52416000	USD
CY2020Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	6928909	shares
CY2020Q2	us-gaap	Noncurrent Assets NoncurrentAssets	18869000	USD
CY2019Q4	us-gaap	Noncurrent Assets NoncurrentAssets	17026000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	65607000	USD
CY2020Q2	us-gaap	Revenues Revenues	115925000	USD
CY2019Q2	us-gaap	Revenues Revenues	86713000	USD
	us-gaap	Revenues Revenues	217753000	USD
	us-gaap	Revenues Revenues	160022000	USD
CY2019	us-gaap	Revenues Revenues	351318000	USD
CY2020Q2	us-gaap	Revenues Revenues	115925000	USD
CY2019Q2	us-gaap	Revenues Revenues	86713000	USD
	us-gaap	Revenues Revenues	217753000	USD
	us-gaap	Revenues Revenues	160022000	USD
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	25474000	USD
CY2019Q2	us-gaap	Cost Of Revenue CostOfRevenue	21106000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	49970000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	40920000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	90451000	USD
	us-gaap	Gross Profit GrossProfit	167783000	USD
	us-gaap	Gross Profit GrossProfit	119102000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29918000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19454000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55190000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36496000	USD
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	28461000	USD
CY2019Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	23708000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	57294000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	46041000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25404000	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21249000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	52012000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41487000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	83783000	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	64411000	USD
	us-gaap	Operating Expenses OperatingExpenses	164496000	USD
	us-gaap	Operating Expenses OperatingExpenses	124024000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	6668000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1196000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	3287000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4922000	USD
CY2020Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	2617000	USD
CY2019Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1239000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	5049000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	3610000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4051000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1762000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8532000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2396000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1227000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7369000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4888000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	1655000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-1270000	USD
	us-gaap	Net Income Loss NetIncomeLoss	5607000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13420000	USD
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100718893	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96356317	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100298230	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95583802	shares
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107647802	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96356317	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107897907	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95583802	shares
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18770000	USD
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13732000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35327000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23381000	USD

Files In Submission

Name	View Source	Status
0001645113-20-000105-index-headers.html	Edgar Link	pending
0001645113-20-000105-index.html	Edgar Link	pending
0001645113-20-000105.txt	Edgar Link	pending
0001645113-20-000105-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvcr-20200630.htm	Edgar Link	pending
nvcr-20200630.xsd	Edgar Link	pending
nvcr-20200630xexx311.htm	Edgar Link	pending
nvcr-20200630xexx312.htm	Edgar Link	pending
nvcr-20200630xexx321.htm	Edgar Link	pending
nvcr-20200630xexx322.htm	Edgar Link	pending
nvcr-20200630_cal.xml	Edgar Link	unprocessable
nvcr-20200630_def.xml	Edgar Link	unprocessable
nvcr-20200630_g1.jpg	Edgar Link	pending
nvcr-20200630_htm.xml	Edgar Link	completed
nvcr-20200630_lab.xml	Edgar Link	unprocessable
nvcr-20200630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVCR
NovoCure Ltd Stock $nvcr

2020 Q2 Form 10-Q Financial Statement

#000164511320000105 Filed on July 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVCR NovoCure Ltd Stock $nvcr

2020 Q2 Form 10-Q Financial Statement

#000164511320000105 Filed on July 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVCR
NovoCure Ltd Stock $nvcr